ROCKVILLE, MD, UNITED STATES, March 25, 2019 /EINPresswire.com/ — American Gene Technologies (AGT), a leading gene and cell therapy biotech company based in Rockville, Md., has established an advisory group… [Read More]
AGT Granted Fifth Patent Protecting Its Immunotherapy Cancer Cure Asset
ROCKVILLE, MD, UNITED STATES, March 21, 2019 /EINPresswire.com/ — American Gene Technologies (AGT) recently was awarded a fifth immuno-oncology patent (“Methods and Composition for the Activation of Gamma Delta T… [Read More]
American Gene Technologies (AGT) Granted Three New Patents in its HIV Cure and Immuno-oncology Programs
ROCKVILLE, MD, UNITED STATES, August 22, 2018 /EINPresswire.com/ — AGT announces the receipt of three foundational patents. Two new patents focus on the immuno-oncology program and add to AGT’s broad… [Read More]
American Gene Technologies Gains Additional Immuno-Oncology Patent
Novel approach to activating gamma delta T cells shows promise in animal studies — demonstrating efficacy in multiple epithelial solid tumors and metastases ROCKVILLE, Md., March 19, 2018 (GLOBE NEWSWIRE) —… [Read More]
American Gene Technologies Receives U.S. Patent on Novel Immuno-Oncology Methods of Treating Cancer through Activation of Gamma Delta T Cells
Patent encompasses AGT’s advanced gene and cell therapy strategy for oncology ROCKVILLE, MD, December 12, 2017 — American Gene Technologies International Inc. (AGT), a leading gene and cell therapy company, today… [Read More]
